Abstract:Objective: To investigate whether it is feasible to use the chondrogenic microenvironment provided by cartilage cells to construct cartilage tissues in vitro with bone marrow stromal cells (BMSC). Materials and Methods: We isolated and cultured BMSC and cartilage cells from Sprague Dawley rats (SD rats). The supernatant of cartilage culture was used as inducing solution to cause differentiation of BMSC from the second generation of cells cultured in vitro. Cells were examined seven days later, using immunohistochemistry to determine the expression of collagen specific to type II cartilage. RT-PCR was used to detect the expression of type II collagen and aggrecan mRNA. BMSC and cartilage cells were isolated from SD rats and cultured in vitro. The BMSC and cartilage cells in culture were mixed evenly in an 8:2 ratio and inoculated into a polyglycolic acid/polylactic acid (PGA/PLA) scaffold to a final concentration of 5.0x107 cells/ml. PGA/PLA preparations with pure cartilage cells or pure BMSC served as the positive and negative controls, respectively. The control group of low-concentration cartilage cells consisted of PGA/PLA preparations containing cartilage cells at 20% of the abovementioned concentration (1.0x107 cells/ml). Samples were collected eight weeks later, at which time general observations, wet weight, and glycosaminoglycan (GAG) levels were determined, and histological and immunohistochemical examinations were performed. Results: Immunohistochemistry showed the induction of BMSC type II collagen, and RT-PCR indicated the expression of type II collagen and aggrecan mRNA. In the mixed-cell group and the positive control group, pure mature cartilage cells were produced after eight weeks of culture in vitro, and the size and shape of the scaffold were maintained throughout the culture period. The two groups gave rise to newly generated cartilage cells essentially identical in appearance and histological properties. The immunohistochemical results showed that the cartilage cells of both groups expressed abundant cartilage-specific type II collagen. The average wet weight and GAG content were more than 70% of the values in the positive control group. Only an extremely small amount of immature cartilage tissue formed in local regions in the BMSC-only sample, and the scaffold was obviously shrunken and deformed. Although the wet weight of newly generated cartilage tissue in the low-concentration cartilage cell sample reached 30% of the value of the positive control group, the scaffold was obviously shrunken and deformed. Only regional and discontinuous cartilage tissues were formed, and the amount of newly generated cartilage was obviously less than in the co-culture and positive control groups. Conclusions: Cartilage cells can provide a microenvironment for cartilage formation to some extent, and also effectively induce BMSC to differentiate into cartilage cells and form tissue-engineered cartilage in vitro.

Increased Expression of Sox9 During Balance of BMSCs/Chondrocyte Bricks in Platelet-Rich Plasma Promotes Construction of a Stable 3-D Chondrogenesis Microenvironment for BMSCs

Cell-bricks Based Injectable Niche Guided Persistent Ectopic Chondrogenesis of Bone Marrow-Derived Mesenchymal Stem Cells and Enabled Nasal Augmentation.

Co-culture of Chondrocytes and Bone Marrow Mesenchymal Stem Cells in Vitro Enhances the Expression of Cartilaginous Extracellular Matrix Components

Chondrogenic Differentiation of ChM‐I Gene Transfected Rat Bone Marrow‐derived Mesenchymal Stem Cells on 3‐dimensional Poly (l‐lactic Acid) Scaffold for Cartilage Engineering

The Role of Bfgf in Down-Regulating Α-Sma Expression of Chondrogenically Induced BMSCs and Preventing the Shrinkage of BMSC Engineered Cartilage.

Angiogenic Potential of Human Bone Marrow-Derived Mesenchymal Stem Cells in Chondrocyte Brick-Enriched Constructs Promoted Stable Regeneration of Craniofacial Cartilage.

Construction of tissue engineered cartilage with Sox9 gene transfection human umbilical cord blood-derived mes-enchymal stem cells and BMG/fibrin

[The Study on the Role of the Soluble Factors Secreted by Engineered Cartilage in Inducing Bone Marrow Stromal Cells Chondrogenesis].

Sox9 Potentiates BMP2-Induced Chondrogenic Differentiation and Inhibits BMP2-Induced Osteogenic Differentiation

Dynamic Mechanical Loading Facilitated Chondrogenic Differentiation of Rabbit BMSCs in Collagen Scaffolds

Conditioned medium from chondrocyte/scaffold constructs induced chondrogenic differentiation of bone marrow stromal cells.

Co-expression of BMP2 and Sox9 Promotes Chondrogenic Differentiation of Mesenchymal Stem Cells in Vitro

In Vitro Study of Nano-Ha/plla Composite Scaffold for Rabbit BMSC Differentiation under TGF-β1 Induction

Proliferative and Chondrogenic Potential of Peripheral Blood Mesenchymal Stem Cells in Demineralized Cancellous Bone Scaffolds

Effects of Chondrogenic Microenvironment on Construction of Cartilage Tissues Using Marrow Stromal Cells in Vitro.

In vitro fibrocartilage construction with bone marrow-derived mesenchymal stem cells-fully demineralized bone matrix

Mechanical Stimulation Promote the Chondrogenesis of Bone Marrow Stromal Cells in Vitro

Characterization of Sox9-overexpressing Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells-Based Engineered Cartilage Both in Vitro and in Vivo.

Xenogeneic Chondrocytes Promote Stable Subcutaneous Chondrogenesis of Bone Marrow-Derived Stromal Cells.

Chondrogenic Ability of Bone Marrow Mesenchymal Stem Cells in Alginate and Collagen Sponge

Isolated Co-Culture of Bone Mesenchymal Stem Cells and Auricular Chondrocytes to Construct Cartilage